Cirrhosis risk factors: Difference between revisions
Jump to navigation
Jump to search
| Line 10: | Line 10: | ||
==Risk Factors== | ==Risk Factors== | ||
*Chronic [[alcohol abuse]]: Regular moderate alcohol consumption is the most common cause of cirrhosis in the United States and other western countries. | *Chronic [[alcohol abuse]]: Regular moderate alcohol consumption is the most common cause of cirrhosis in the United States and other western countries.<ref name="pmid9462221">{{cite journal |vauthors=Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M, Saveria Crocè L, Sasso F, Pozzato G, Cristianini G, Brandi G |title=Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group |journal=Gut |volume=41 |issue=6 |pages=845–50 |year=1997 |pmid=9462221 |pmc=1891602 |doi= |url=}}</ref> | ||
*Chronic Hepatitis B and C viruses and perhaps other viruses, can damage the liver over a prolonged time and eventually cause cirrhosis. This is the most common cause of cirrhosis in some Asian countries. | *Chronic Hepatitis B and C viruses and perhaps other viruses, can damage the liver over a prolonged time and eventually cause cirrhosis. This is the most common cause of cirrhosis in some Asian countries. | ||
*[[Autoimmune hepatitis]]: The body's protective antibodies injure the liver cells because they fail to recognize the liver as its own tissue. | *[[Autoimmune hepatitis]]: The body's protective antibodies injure the liver cells because they fail to recognize the liver as its own tissue. | ||
| Line 18: | Line 18: | ||
*[[Nonalcoholic fatty liver disease]] | *[[Nonalcoholic fatty liver disease]] | ||
*Drugs and [[toxins]]: Studies demonstrate that prolonged exposure to certain chemicals or drugs can damage the liver. | *Drugs and [[toxins]]: Studies demonstrate that prolonged exposure to certain chemicals or drugs can damage the liver. | ||
*Age above 50 years | *Age above 50 years <ref name="pmid9121257">{{cite journal |vauthors=Poynard T, Bedossa P, Opolon P |title=Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups |journal=Lancet |volume=349 |issue=9055 |pages=825–32 |year=1997 |pmid=9121257 |doi= |url=}}</ref> | ||
*Male gender | *Male gender <ref name="pmid10323892">{{cite journal |vauthors=Bellentani S, Pozzato G, Saccoccio G, Crovatto M, Crocè LS, Mazzoran L, Masutti F, Cristianini G, Tiribelli C |title=Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study |journal=Gut |volume=44 |issue=6 |pages=874–80 |year=1999 |pmid=10323892 |pmc=1727553 |doi= |url=}}</ref> | ||
*Features of metabolic syndrome in Non Alcoholic Steato Heaptitis(NASH): | *Features of metabolic syndrome in Non Alcoholic Steato Heaptitis(NASH): <ref name="pmid16540768">{{cite journal |vauthors=Clark JM |title=The epidemiology of nonalcoholic fatty liver disease in adults |journal=J. Clin. Gastroenterol. |volume=40 Suppl 1 |issue= |pages=S5–10 |year=2006 |pmid=16540768 |doi=10.1097/01.mcg.0000168638.84840.ff |url=}}</ref><ref name="pmid16447287">{{cite journal |vauthors=Farrell GC, Larter CZ |title=Nonalcoholic fatty liver disease: from steatosis to cirrhosis |journal=Hepatology |volume=43 |issue=2 Suppl 1 |pages=S99–S112 |year=2006 |pmid=16447287 |doi=10.1002/hep.20973 |url=}}</ref> | ||
**Obesity | **Obesity | ||
**Insulin resistance/type 2 diabetes | **Insulin resistance/type 2 diabetes | ||
Revision as of 15:21, 4 December 2017
|
Cirrhosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case studies |
|
Cirrhosis risk factors On the Web |
|
American Roentgen Ray Society Images of Cirrhosis risk factors |
|
Risk calculators and risk factors for Cirrhosis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Certain aspects of genetics and lifestyle can put someone at risk for cirrhosis. Chronic alcohol use, or the development of a fatty liver can put one at risk for cirrhosis. Genetic diseases such as cystic fibrosis, and hemochromatosis, and not genetic diseases such as hepatitis B and hepatitis C, are also significant risk factors for the development of cirrhosis.
Risk Factors
- Chronic alcohol abuse: Regular moderate alcohol consumption is the most common cause of cirrhosis in the United States and other western countries.[1]
- Chronic Hepatitis B and C viruses and perhaps other viruses, can damage the liver over a prolonged time and eventually cause cirrhosis. This is the most common cause of cirrhosis in some Asian countries.
- Autoimmune hepatitis: The body's protective antibodies injure the liver cells because they fail to recognize the liver as its own tissue.
- Chronic bile duct blockage
- Wilson's Disease or hemochromatosis: Metals are present in all body cells. When abnormal amounts of them accumulate in the liver, scarring and cirrhosis may develop.
- Cystic fibrosis and Alpha l-antitrypsin deficiency
- Nonalcoholic fatty liver disease
- Drugs and toxins: Studies demonstrate that prolonged exposure to certain chemicals or drugs can damage the liver.
- Age above 50 years [2]
- Male gender [3]
- Features of metabolic syndrome in Non Alcoholic Steato Heaptitis(NASH): [4][5]
- Obesity
- Insulin resistance/type 2 diabetes
- Hypertension
- Hyperlipidemia
References
- ↑ Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M, Saveria Crocè L, Sasso F, Pozzato G, Cristianini G, Brandi G (1997). "Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group". Gut. 41 (6): 845–50. PMC 1891602. PMID 9462221.
- ↑ Poynard T, Bedossa P, Opolon P (1997). "Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups". Lancet. 349 (9055): 825–32. PMID 9121257.
- ↑ Bellentani S, Pozzato G, Saccoccio G, Crovatto M, Crocè LS, Mazzoran L, Masutti F, Cristianini G, Tiribelli C (1999). "Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study". Gut. 44 (6): 874–80. PMC 1727553. PMID 10323892.
- ↑ Clark JM (2006). "The epidemiology of nonalcoholic fatty liver disease in adults". J. Clin. Gastroenterol. 40 Suppl 1: S5–10. doi:10.1097/01.mcg.0000168638.84840.ff. PMID 16540768.
- ↑ Farrell GC, Larter CZ (2006). "Nonalcoholic fatty liver disease: from steatosis to cirrhosis". Hepatology. 43 (2 Suppl 1): S99–S112. doi:10.1002/hep.20973. PMID 16447287.